Selection of antihypertensive therapy in elderly patients, combination therapy: thiazide-like diuretics and calcium channel blockers
https://doi.org/10.15829/1560-4071-2018-11-117-122
Abstract
The article presents data about the prevalence and expected prognosis for arterial hypertension. Emphasis is placed on the selection of antihypertensive therapy in elderly patients. The features concerning the positive effect of the calcium channelblocking agent — amlodipine, thiazidlike diuretic — indapamide retard in the form of monotherapy and a combination of the above drugs on the course and prognosis of arterial hypertension in elderly patients are investigated. A clinical example of the use of the fixed dose combination amlodipine + indapamide retard is also introduced.
About the Authors
z. M. Galeyeva
Kazan State Medical University.
Russian Federation
Russian Federation
A. S. Galyavich
Kazan State Medical University.
Russian Federation
Russian Federation
L. V. Baleyeva
Kazan State Medical University.
Russian Federation
Russian Federation
E. G. Safina
Kazan State Medical University; Interregional Clinical Diagnostic Center.
O. V. Sorokina
Interregional Clinical Diagnostic Center.
Russian Federation
Russian Federation
References
1. 2018 ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal. 2018;39:3021–3104 ESC/ESH GUIDELINES. doi:10.1093/eurheartj/ehy339.
2. Hoy WE, Hughson MD, Bertram JF, et al. Nephron number, hypertension, renal disease and renal failure. Journal American Society of Nephrology. 2005;16:2557-2564. doi: 10.1681/ASN.2005020172.
3. Belmin J, Levy BI, Michel JB. Changes in the renin-angiotensin-aldosterone axis in later life. Drugs and Aging. 1994; Nov;5:391-400. doi.org/10.2165/00002512-199405050-00007
4. Brown MJ. Heterogeneity of blood pressure response to therapy. American Journal of Hypertension. 2010;2:926–928. doi.org/10.1038/ajh.2010.139
5. Vishnevskiy A, Andeev E, Timonin C, et al. Mortality from cardiovascular diseases and life expectancy in Russia. Demographic Review. 2016;3(1):6–34. (In Russ.)
6. Baguet JP, Legallicier B, Auquier P, et al. Updated meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure. Clinical Drug Investigation 2007.27:735–753. https://doi.org/10.2165/00044011-200727110-00001
7. Jadhav U, Hiremath J, Namjoshi DJ, Gujral VK, Tripathi KK, et al. (2014) Blood Pressure Control with a Single-Pill Combination of Indapamide Sustained-Release and Amlodipine in Patients with Hypertension: The EFFICIENT Study. PLoS ONE 9(4): e92955. doi:10.1371/journal.pone.0092955
8. Kobalava Zh D., Shavarova EK. Clinical features of arterial hypertension in the elderly and senile age and the rationale for the use of the amlodipine / indapamide retard combination. Cardiology. 2017;57(8):60–70. (In Russ.)
9. Mulatero P, Verhovez A, Morello F, Veglio F. Diagnosis and treatment of low-renin hypertension. Clinical Endocrinology (Oxf) 2007.67:324–334. doi:10.1111/j.1365-2265.2007.02898.x
10. Egan BM, Bandyopadhyay D, Shaftman SR, et al. Initial monotherapy and combination therapy and hypertension control the first year. Hypertension. 2012.59:1124–1131. doi:10.1161/HYPERTENSIONAHA.112.194167
11. Rimoldi SF., Messerli FH., Chavez P, et al. Efficacy and Safety of Calcium Channel Blocker / Diuretics Combination Therapy in Hypertensive Patients: A Meta-Analysis. Journal of Clinical Hypertension. 2015;17:193–199. doi:10.1111/jch.12462
12. Zhang Y, Agnoletti D, Safar ME, Blacher J. Hypertension. Effect of antihypertensive agents on blood pressure variability: the Natrilix SR versus candesartan and amlodipine in the reduction of systolic blood pressure in hypertensive patients (X-CELLENT) study. 2011.Aug;58(2):155-60. doi:0.1161/HYPERTENSIONAHA.111.174383.
13. Tzourio C, Anderson C, Chapman N, et al. PROGRESS Collaborative Group. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Archives of Internal Medicine. 2003;163:1069–1075. doi:10.1001/archinte.163.9.1069.
14. Ostroumova OD, Starodubova AV, Ostroumova TM, Chernyaeva MS. Cognitive impairment and dementia in elderly patients with arterial hypertension. Cardiology. 2018;58(10): 69–76. (In Russ.)
15. Forette F, Seux ML, Staessen JA, Thijs L, Babarskiene MR, Babeanu S, Bossini A, Fagard R, Gil-Extremera B, Laks T, Kobalava Z, Sarti C, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, Birkenhger WH. Systolic Hypertension in Europe Investigators. The Prevention of Dementia with Antihypertensive Treatment. New evidence from the Systolic Hypertension (Syst-Eur) Study. Archives of Internal Medicine. 2002.Oct.14;162(18):2046-52. PMID:12374512. doi:10.1001/archinte.162.18.2046
Review
For citations:
Galeyeva z.M., Galyavich A.S., Baleyeva L.V., Safina E.G., Sorokina O.V. Selection of antihypertensive therapy in elderly patients, combination therapy: thiazide-like diuretics and calcium channel blockers. Russian Journal of Cardiology. 2018;(11):117-122. (In Russ.) https://doi.org/10.15829/1560-4071-2018-11-117-122
Views:
3202
Email this article 